 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Homology Medicines Inc. (FIXX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-10-01 Sale | 2019-10-02 4:08 pm | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $17.39 | $104,367 | 133,404 (Direct) | View |
| 2019-10-01 Sale | 2019-10-02 4:08 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR CEO | 12,500 | $17.4 | $217,468 | 127,605 (Direct) | View |
| 2019-10-01 Sale | 2019-10-02 4:07 pm | Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer | 9,300 | $17.39 | $161,759 | 181,850 (Direct) | View |
| 2019-09-05 Sale | 2019-09-09 4:05 pm | Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks | 1,166 | $19.94 | $23,251 | 0 (Direct) | View |
| 2019-09-03 Sale | 2019-09-05 4:42 pm | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $18.74 | $112,419 | 139,404 (Direct) | View |
| 2019-09-03 Sale | 2019-09-05 4:40 pm | Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer | 9,300 | $18.74 | $174,284 | 191,050 (Direct) | View |
| 2019-09-03 Sale | 2019-09-05 4:39 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR CEO | 12,500 | $18.75 | $234,320 | 140,005 (Direct) | View |
| 2019-08-01 Sale | 2019-08-05 4:18 pm | Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer | 9,300 | $17.37 | $161,523 | 200,350 (Direct) | View |
| 2019-08-01 Sale | 2019-08-05 4:16 pm | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $17.37 | $104,191 | 145,404 (Direct) | View |
| 2019-08-01 Sale | 2019-08-05 4:15 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR CEO | 12,500 | $17.37 | $217,111 | 152,505 (Direct) | View |
| 2019-07-09 Sale | 2019-07-11 4:30 pm | Homology Medicines Inc. | FIXX | Rasty Siyamak COO | 8,000 | $20 | $160,000 | 222,707 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:32 pm | Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer | 9,300 | $18.98 | $176,539 | 209,750 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:30 pm | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $19 | $113,971 | 151,404 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:30 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR CEO | 12,500 | $18.98 | $237,300 | 165,005 (Direct) | View |
| 2019-06-03 Sale | 2019-06-05 6:16 pm | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $19.94 | $119,664 | 157,404 (Direct) | View |
| 2019-06-03 Sale | 2019-06-05 6:13 pm | Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks | 1,288 | $20 | $25,765 | 0 (Direct) | View |
| 2019-06-03 Sale | 2019-06-05 6:11 pm | Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer | 9,300 | $19.9 | $185,093 | 218,950 (Direct) | View |
| 2019-06-03 Sale | 2019-06-05 6:10 pm | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR CEO | 12,500 | $19.86 | $248,263 | 177,505 (Direct) | View |
| 2019-06-03 Sale | 2019-06-05 6:09 pm | Homology Medicines Inc. | FIXX | Rasty Siyamak COO | 8,000 | $20.22 | $161,778 | 230,707 (Direct) | View |
| 2019-05-16 Sale | 2019-05-20 4:26 pm | Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner | 615,000 | $21.47 | $13,204,050 | 5,314,484 (Indirect) | View |
| 2019-05-16 Sale | 2019-05-20 4:24 pm | Homology Medicines Inc. | FIXX | PARMAR KUSH Director, 10% Owner | 615,000 | $21.47 | $13,204,050 | 5,314,484 (Indirect) | View |
| 2019-04-12 Purchase | 2019-04-15 7:38 pm | Homology Medicines Inc. | FIXX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt III L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Mgmt HIF L.P. Director, 10% Owner | 533,333 | $22.5 | $11,999,992 | 2,613,517 (Indirect) | View |
| 2018-12-10 Sale | 2018-12-12 8:10 pm | Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner | 15,575 | $26.01 | $405,029 | 5,904,884 (Indirect) | View |
| 2018-12-10 Sale | 2018-12-12 8:10 pm | Homology Medicines Inc. | FIXX | PARMAR KUSH Director, 10% Owner | 15,575 | $26.01 | $405,029 | 5,904,884 (Indirect) | View |
| 2018-11-23 Sale | 2018-11-27 6:09 pm | Homology Medicines Inc. | FIXX | PARMAR KUSH Director, 10% Owner | 29,682 | $20.04 | $594,709 | 5,919,836 (Indirect) | View |
| 2018-11-23 Sale | 2018-11-27 6:08 pm | Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner | 29,682 | $20.04 | $594,709 | 5,919,836 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-10-01 Exercise | 2019-10-02 4:08 pm | N/A N/A | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 133,404 (Direct) | View |
| 2019-10-01 Exercise | 2019-10-02 4:08 pm | N/A 2027-04-05 | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 133,404 (Direct) | View |
| 2019-09-03 Exercise | 2019-09-05 4:42 pm | N/A N/A | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 139,404 (Direct) | View |
| 2019-09-03 Exercise | 2019-09-05 4:42 pm | N/A 2027-04-05 | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 139,404 (Direct) | View |
| 2019-08-01 Exercise | 2019-08-05 4:16 pm | N/A N/A | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 145,404 (Direct) | View |
| 2019-08-01 Exercise | 2019-08-05 4:16 pm | N/A 2027-04-05 | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 145,404 (Direct) | View |
| 2019-07-11 Option Award | 2019-07-15 5:36 pm | N/A 2029-07-11 | Homology Medicines Inc. | FIXX | REICIN ALISE Director | 31,160 | $19.25 | 31,160 (Direct) | View |
| 2019-07-01 Exercise | 2019-07-03 4:30 pm | N/A N/A | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 151,404 (Direct) | View |
| 2019-07-01 Exercise | 2019-07-03 4:30 pm | N/A 2027-04-05 | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 151,404 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-11 7:33 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | Wheeler Cameron Director | 15,580 | $19.51 | 15,580 (Indirect) | View |
| 2019-06-06 Option Award | 2019-06-11 4:47 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director, 10% Owner | 15,580 | $19.51 | 15,580 (Indirect) | View |
| 2019-06-06 Option Award | 2019-06-10 5:11 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | Gregory Richard J. Director | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:11 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | Wheeler Cameron Director | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:11 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | Thistle Mary Director | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:10 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | Patterson Matthew R Director | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:09 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | PARMAR KUSH Director, 10% Owner | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:09 pm | N/A 2029-06-06 | Homology Medicines Inc. | FIXX | GILLIS STEVEN Director | 15,580 | $19.51 | 15,580 (Direct) | View |
| 2019-06-03 Exercise | 2019-06-05 6:16 pm | N/A N/A | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 157,404 (Direct) | View |
| 2019-06-03 Exercise | 2019-06-05 6:16 pm | N/A 2027-04-05 | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 6,000 | $0.64 | 157,404 (Direct) | View |
| 2019-05-21 Other | 2019-05-23 5:58 pm | N/A N/A | Homology Medicines Inc. | FIXX | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH NELSEN ROBERT 10% Owner | 300,001 | $0 | 5,768,694 (Direct) | View |
| 2018-12-14 Option Award | 2018-12-18 5:27 pm | N/A 2028-12-14 | Homology Medicines Inc. | FIXX | Seymour Albert Chief Scientific Officer | 74,000 | $24.28 | 74,000 (Direct) | View |
| 2018-12-14 Option Award | 2018-12-18 5:25 pm | N/A 2028-12-14 | Homology Medicines Inc. | FIXX | Kelly Timothy P See Remarks | 66,000 | $24.28 | 66,000 (Direct) | View |
| 2018-12-14 Option Award | 2018-12-18 5:21 pm | N/A 2028-12-14 | Homology Medicines Inc. | FIXX | TZIANABOS ARTHUR CEO | 203,000 | $24.28 | 203,000 (Direct) | View |
| 2018-12-14 Option Award | 2018-12-18 5:20 pm | N/A 2028-12-14 | Homology Medicines Inc. | FIXX | Smith W Bradford CFO | 88,000 | $24.28 | 88,000 (Direct) | View |
| © 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 Wed, 13 Nov 2019 19:56:06 -0600 | SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |